California HealthSpan Institute
California HealthSpan Institute
  • Home
  • Hormone Therapy Program
    • Hormone Therapy
    • Treatment Program
    • Program benefits
    • Supplements Micronutrient
    • DNA Teleomeres
    • NAD +
    • FAQ
    • Synthetic vs. Bio-Hormone
  • Events & Presentations
    • Upcoming Events
    • News
    • Presentations & Webinars
    • Educational Videos
  • References & Citations
    • Recommended Reading
    • Cortisol
    • DHEA
    • Estrogen
    • Growth Hormone
    • Melatonin
    • Pregnenlone
    • Progesterone
    • Testosterone Therapy
    • Thyroid
  • Team of experts
  • Contact Us
  • Privacy Policy
  • More
    • Home
    • Hormone Therapy Program
      • Hormone Therapy
      • Treatment Program
      • Program benefits
      • Supplements Micronutrient
      • DNA Teleomeres
      • NAD +
      • FAQ
      • Synthetic vs. Bio-Hormone
    • Events & Presentations
      • Upcoming Events
      • News
      • Presentations & Webinars
      • Educational Videos
    • References & Citations
      • Recommended Reading
      • Cortisol
      • DHEA
      • Estrogen
      • Growth Hormone
      • Melatonin
      • Pregnenlone
      • Progesterone
      • Testosterone Therapy
      • Thyroid
    • Team of experts
    • Contact Us
    • Privacy Policy
Call Today 760-635-1996

  • Home
  • Hormone Therapy Program
    • Hormone Therapy
    • Treatment Program
    • Program benefits
    • Supplements Micronutrient
    • DNA Teleomeres
    • NAD +
    • FAQ
    • Synthetic vs. Bio-Hormone
  • Events & Presentations
    • Upcoming Events
    • News
    • Presentations & Webinars
    • Educational Videos
  • References & Citations
    • Recommended Reading
    • Cortisol
    • DHEA
    • Estrogen
    • Growth Hormone
    • Melatonin
    • Pregnenlone
    • Progesterone
    • Testosterone Therapy
    • Thyroid
  • Team of experts
  • Contact Us
  • Privacy Policy
Call Today 760-635-1996

Pregnenolone

 Marx CE et al. Proof of concept trial with the neurosteroid prenenolone targeting cognitive and negative symptoms in schizophrenia. . Psychoneuroendocrinology. 2009 July;34(8):1885-903 

Copyright © 2026 ehealth - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept